Related Experiment Video
Updated: May 9, 2025
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
30.3K
Hypertonic liquids: a potential method for reducing super absorbent polymer bead associated bowel obstructions in
Brian C Gulack1, Jacky Kwong2, Gwyneth Sullivan2
1Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, 1725 West Harrison Street, Professional Building Suite 710, Chicago, IL, 60612, USA. brian_gulack@rush.edu.
Pediatric Surgery International
|April 30, 2025
Summary
Certain hypertonic liquids, like fruit juices and Gastrografin, can prevent super absorbent polymer (SAP) bead growth and shrinkage. This may help prevent small bowel obstruction (SBO) after ingestion in children.
Area of Science:
- Pediatric Gastroenterology
- Toxicology
- Materials Science
Background:
- Super absorbent polymer (SAP) beads pose a risk of small bowel obstruction (SBO) if ingested by children.
- Limited data exists on managing pediatric SBO caused by SAP bead ingestion.
- Hypertonic liquids are hypothesized to mitigate SAP bead growth and prevent SBO.
Purpose of the Study:
- To investigate the efficacy of various hypertonic liquids in limiting SAP bead growth.
- To determine if hypertonic liquids can induce shrinkage of pre-hydrated SAP beads.
- To evaluate potential liquid-based interventions for preventing SBO after SAP bead ingestion.
Main Methods:
- A range of hypertonic liquids were tested, including 100% fruit juices, mineral oil, Gastrografin, and others.
- Simulated intestinal fluid served as the control for comparison.
- SAP bead growth and shrinkage were quantified after 24-hour hydration using regression analysis.
Main Results:
- Mineral oil, Gastrografin, and 100% fruit juices significantly inhibited SAP bead growth compared to the control.
- 100% fruit juices demonstrated the greatest efficacy in shrinking pre-hydrated SAP beads.
- Statistical analysis confirmed the significance of these findings (p < 0.001).
Conclusions:
- Gastrografin and 100% fruit juices show promise in controlling SAP bead size post-ingestion.
- Liquid-based protocols utilizing these agents may prevent SBO and reduce the need for surgery.
- Further clinical evaluation is warranted to confirm the therapeutic potential of these findings.
Related Concept Videos
01:20Drugs Affecting GI Tract Motility: Other Laxatives
122
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
122
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
144
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
144
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
126
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
126
01:21Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109
01:22Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
133
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
133
01:17Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117